Nervonic acidCAS# 506-37-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 506-37-6 | SDF | Download SDF |
PubChem ID | 5281120 | Appearance | White crystalline powder |
Formula | C24H46O2 | M.Wt | 366.62 |
Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (Z)-tetracos-15-enoic acid | ||
SMILES | CCCCCCCCC=CCCCCCCCCCCCCCC(=O)O | ||
Standard InChIKey | GWHCXVQVJPWHRF-KTKRTIGZSA-N | ||
Standard InChI | InChI=1S/C24H46O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26/h9-10H,2-8,11-23H2,1H3,(H,25,26)/b10-9- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Nervonic acid can inhibit DNA polymerase beta and HIV-1 reverse transcriptase. 2. Nervonic Acid improves learning memory ability in normal mice and mice with experimental memory impairment. |
Targets | HIV |
Nervonic acid Dilution Calculator
Nervonic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7276 mL | 13.6381 mL | 27.2762 mL | 54.5524 mL | 68.1905 mL |
5 mM | 0.5455 mL | 2.7276 mL | 5.4552 mL | 10.9105 mL | 13.6381 mL |
10 mM | 0.2728 mL | 1.3638 mL | 2.7276 mL | 5.4552 mL | 6.819 mL |
50 mM | 0.0546 mL | 0.2728 mL | 0.5455 mL | 1.091 mL | 1.3638 mL |
100 mM | 0.0273 mL | 0.1364 mL | 0.2728 mL | 0.5455 mL | 0.6819 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Arachidonic acid
Catalog No.:BCN2215
CAS No.:506-32-1
- Isojacareubin
Catalog No.:BCN6883
CAS No.:50597-93-8
- Columbianadin
Catalog No.:BCN1275
CAS No.:5058-13-9
- Fenspiride HCl
Catalog No.:BCC4659
CAS No.:5053-08-7
- 3-(Carboxymethylamino)propanoic acid
Catalog No.:BCN1791
CAS No.:505-72-6
- Homopiperazine
Catalog No.:BCC8995
CAS No.:505-66-8
- Araneosol
Catalog No.:BCN5613
CAS No.:50461-86-4
- GW441756
Catalog No.:BCC5093
CAS No.:504433-23-2
- Methyl 2alpha-hydroxyhardwickiate
Catalog No.:BCN7595
CAS No.:50428-93-8
- 1,5,6-Trihydroxyxanthone
Catalog No.:BCN7642
CAS No.:5042-03-5
- Isorhamnetin-3-O-beta-D-Glucoside
Catalog No.:BCN1247
CAS No.:5041-82-7
- Isoliquiritin
Catalog No.:BCN5945
CAS No.:5041-81-6
- Octacosanoic Acid
Catalog No.:BCN5395
CAS No.:506-48-9
- Niranthin
Catalog No.:BCN5614
CAS No.:50656-77-4
- Alkaloid KD1
Catalog No.:BCN1898
CAS No.:50656-87-6
- Alkaloid C
Catalog No.:BCN1897
CAS No.:50656-88-7
- Vandrikidine
Catalog No.:BCN5615
CAS No.:50656-92-3
- Chasmanine
Catalog No.:BCN5409
CAS No.:5066-78-4
- Terfenadine
Catalog No.:BCC3866
CAS No.:50679-08-8
- Boc-Cys(Bzl)-OH
Catalog No.:BCC3376
CAS No.:5068-28-0
- Borneol
Catalog No.:BCN4964
CAS No.:507-70-0
- Pennogenin
Catalog No.:BCN2839
CAS No.:507-89-1
- Vecuronium Bromide
Catalog No.:BCC2498
CAS No.:50700-72-6
- 3-Cyano-6-isopropylchromone
Catalog No.:BCC8627
CAS No.:50743-32-3
Sensitivity of fatty acid desaturation and elongation to plasma zinc concentration: a randomised controlled trial in Beninese children.[Pubmed:29352828]
Br J Nutr. 2018 Mar;119(6):610-619.
Zn status may affect fatty acid (FA) metabolism because it acts as a cofactor in FA desaturase and elongase enzymes. Zn supplementation affects the FA desaturases of Zn-deficient rats, but whether this occurs in humans is unclear. We evaluated the associations between baseline plasma Zn (PZn) concentration and plasma total phospholipid FA composition, as well as the effect of daily consumption of Zn-fortified water on FA status in Beninese children. A 20-week, double-blind randomised controlled trial was conducted in 186 school age children. The children were randomly assigned to receive a daily portion of Zn-fortified, filtered water delivering on average 2.8 mg Zn/d or non-fortified filtered water. Plasma total phospholipid FA composition was determined using capillary GLC and PZn concentrations by atomic absorption spectrometry. At baseline, PZn correlated positively with dihomo-gamma-linolenic acid (DGLA, r 0.182; P=0.024) and the DGLA:linoleic acid (LA) ratio (r 0.293; P<0.000), and negatively with LA (r -0.211; P=0.009) and the arachidonic acid:DGLA ratio (r -0.170; P=0.036). With the intervention, Zn fortification increased Nervonic acid (B: 0.109; 95 % CI 0.001, 0.218) in all children (n 186) and more so in children who were Zn-deficient (n 60) at baseline (B: 0.230; 95 % CI 0.023, 0.488). In conclusion, in this study, Zn-fortified filtered water prevented the reduction of Nervonic acid composition in the plasma total phospholipids of children, and this effect was stronger in Zn-deficient children. Thus, Zn status may play an important role in FA desaturation and/or elongation.
Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.[Pubmed:29580494]
Food Res Int. 2018 May;107:346-352.
Citrus juices, especially orange juice, constitute rich sources of bioactive compounds with a wide range of health-promoting activities. Data from epidemiological and in vitro studies suggest that orange juice (OJ) may have a positive impact on lipid metabolism. However, the effect of orange juice intake on blood lipid profile is still poorly understood. We have used two different blood samples, Dried Blood Spots (DBS) and plasma, to assess the effect of two-week orange juice consumption in healthy volunteers by a mass-spectrometry based metabolomics approach. DBS were analysed by liquid chromatography mass spectrometry (LC-MS) and plasma samples were analysed by the gas chromatography mass spectrometry (GC-MS). One hundred sixty-nine lipids including acylcarnitines (AC), lysophosphatidylcholines (LysoPC), (diacyl- and acyl-alkyl-) phosphatidylcholines (PC aa and PC ae) and sphingomyelins (SM) were identified and quantified in DBS. Eighteen fatty acids were identified and quantified in plasma. Multivariate analysis allowed to identify an increase in C3:1, C5-DC(C6-OH), C5-M-DC, C5:1-DC, C8, C12-DC, lysoPC18:3, myristic acid, pentadecanoic acid, palmitoleic and palmitic acid and a decrease in Nervonic acid, C0, C2, C10, C10:1, C16:1, C16-OH, C16:1-OH, C18-OH, PC aa C40:4, PC ae C38:4, PC ae C42:3, PC ae C42:4 and cholesterol levels after orange juice intake. A two-week period of orange juice intake could affect fatty acids beta-oxidation through mitochondrial and peroxisomal pathways, leading to an increase of short-chain acylcarnitines and a decrease of medium and long-chain acylcarnitines. This is the first report analyzing the effect of orange juice intake in healthy volunteers using a dried blood spot-based metabolomics approach.
Antimycoplasmal Activities of Compounds from Solanum aculeastrum and Piliostigma thonningii against Strains from the Mycoplasma mycoides Cluster.[Pubmed:29311927]
Front Pharmacol. 2017 Dec 21;8:920.
Infections caused by Mycoplasma species belonging to the 'mycoides cluster' negatively affect the agricultural sector through losses in livestock productivity. These Mycoplasma strains are resistant to many conventional antibiotics due to the total lack of cell wall. Therefore, there is an urgent need to develop new antimicrobial agents from alternative sources such as medicinal plants to curb the resistance threat. Recent studies on extracts from Solanum aculeastrum and Piliostigma thonningii revealed interesting antimycoplasmal activities hence the motivation to investigate the antimycoplasmal activities of constituent compounds. The CH2Cl2/MeOH extracts from the berries of S. aculeastrum yielded a new beta-sitosterol derivative (1) along with six known ones including; lupeol (2), two long-chain fatty alcohols namely undecyl alcohol (3) and lauryl alcohol (4); two long-chain fatty acids namely; myristic acid (5) and Nervonic acid (6) as well as a glycosidic steroidal alkaloid; (25R)-3beta-O-alpha-L-rhamnopyranosyl-(1-->2)-O-[alpha-L-rhamnopyranosyl-(1-->4)] -beta-D-glucopyranosyloxy-22alpha-N-spirosol-5-ene (7) from the MeOH extracts. A new furan diglycoside, (2,5-D-diglucopyranosyloxy-furan) (8) was also characterized from the CH2Cl2/MeOH extract of stem bark of P. thonningii. The structures of the compounds were determined on the basis of spectroscopic evidence and comparison with literature data. Compounds 1, 3, 4, 7, and 8 isolated in sufficient yields were tested against the growth of two Mycoplasma mycoides subsp. mycoides (Mmm), two M. mycoides. capri (Mmc), and one M. capricolum capricolum (Mcc) using broth dilution methods, while the minimum inhibitory concentration (MIC) was determined by serial dilution. The inhibition of Mycoplasma in vitro growth was determined by the use of both flow cytometry (FCM) and color change units (CCU) methods. Compounds 4 and 7 showed moderate activity against the growth of Mmm and Mmc but were inactive against the growth of Mcc. The lowest MIC value was 50 mug/ml for compound 7 against Mmm. The rest of the compounds showed minimal or no activity against the strains of Mycoplasma mycoides tested. This is the first report on the use of combined FCM and CCU to determine inhibition of in vitro growth of Mycoplasma mycoides. The activity of these compounds against other bacterial strains should be tested and their safety profiles determined.
The effect of fish oil supplementation on brain DHA and EPA content and fatty acid profile in mice.[Pubmed:29252041]
Int J Food Sci Nutr. 2018 Sep;69(6):705-717.
Supplementation with omega-3 (n-3) fatty acids may improve cognitive performance and protect against cognitive decline. However, changes in brain phospholipid fatty acid composition after supplementation with n-3 fatty acids are poorly described. The purpose of this study was to feed increasing n-3 fatty acids and characterise the changes in brain phospholipid fatty acid composition and correlate the changes with red blood cells (RBCs) and plasma in mice. Increasing dietary docosahexaenoic (DHA) and eicosapentaenoic acid (EPA) did not alter brain DHA. Brain EPA increased and total n-6 polyunsaturated fatty acids decreased across treatment groups, and correlated with fatty acid changes in the RBC (r > 0.7). Brain cis-monounsaturated fatty acids oleic and Nervonic acid (p < .01) and saturated fatty acids arachidic, behenic, and lignoceric acid (p < .05) also increased. These brain fatty acid changes upon increasing n-3 intake should be further investigated to determine their effects on cognition and neurodegenerative disease.
Naphthylacetic Acid and Tea Polyphenol Application Promote Biomass and Lipid Production of Nervonic Acid-Producing Microalgae.[Pubmed:29731762]
Front Plant Sci. 2018 Apr 17;9:506.
Mychonastes afer HSO-3-1 is a potential producer of Nervonic acid, which could be accumulated to 2-3% of dry cell weight. Improving the productivity of Nervonic acid is critical to promote the commercialization of this product. In this study, 1-naphthylacetic acid (NAA) and tea polyphenol (TP) were selected as bioactive additives to stimulate the growth of M. afer. Supplementing NAA in the early growth stage and TP in the middle and late growth stage led to improved lipid accumulation in M. afer. The cultures supplemented with TP at the late growth stage maintained higher photosynthetic efficiency than the control groups without TP. Furthermore, the intracellular reactive oxygen species (ROS) accumulations in M. afer supplemented with 500 mg/L of TP was 63% lower than the control group. A linear relationship (R(2)= 0.899) between the values of Fv/Fm and ROS accumulation was established. We hypothesize supplement of bioactive additives at different growth stage could promote the cell growth rate and Nervonic acid productivity of M. afer by retrieving intracellular ROS level. Further analysis of photosynthetic system II (PSII) protein in M. afer cultured in presence of NAA and TP indicated the levels of D1 and D2 proteins, the core skeleton proteins of PSII, showed 33.3 and 25.6% higher than the control group. CP43 protein, a critical module in PSII repair cycle, decreased significantly. These implied that TP possesses the function of slowing down the damage of PSII by scavenging excess intracellular ROS.